CHE
CHEMED CORP · Healthcare · Market cap $7.2B
Insiders sold $4.8M net in the last 90 days ·3 sellers, 0 buyers· latest Form 4 filed Sep 30, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.8M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Oct 1, 2026
MCNAMARA KEVIN J
CHEMED CORP (CHE) has 32 SEC Form 4 filings (44 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Oct 1, 2026.
Inside the rolling window, 5 insiders at CHEMED CORP reported no open-market purchases and 13 open-market sales totaling $8.8M. The most active filer is president and CEO MCNAMARA KEVIN J with 8 filings. Insiders have net sold $6.5M over the trailing 6 months. The most recent open-market filing is a sale of 2,000 shares by president and CEO MCNAMARA KEVIN J, dated Sep 28, 2026, worth $1.0M.
- Industry:Medical - Care Facilities
- CEO:Kevin J. McNamara
- Employees:15,811
- HQ:Cincinnati, OH, US
- IPO:1973-05-03
| Source | |||||||
|---|---|---|---|---|---|---|---|
| president and CEO | Sale | 2,000 | $1.0M | Sep 30 | +5.9% | SEC ↗ | |
| president and CEO | Sale | 2,000 | $1.0M | Sep 21 | +7.0% | SEC ↗ | |
LEE SPENCER SFirst filing | executive vice president | Sale | 1,000 | $541K | Aug 24 | -1.2% | SEC ↗ |
| president and CEO | Sale | 2,000 | $1.1M | Aug 24 | -1.2% | SEC ↗ | |
MCNAMARA KEVIN JFirst in 3 months | president and CEO | Sale | 2,000 | $1.1M | Aug 4 | -0.9% | SEC ↗ |
| Director | Sale | 190 | $101K | Aug 3 | -1.1% | SEC ↗ | |
LINDELL ANDREA RFirst filing | Director | Sale | 1,347 | $603K | Jun 10 | +23.1% | SEC ↗ |
WALSH GEORGE J IIIFirst filing | Director | Sale | 500 | $219K | May 29 | +25.4% | SEC ↗ |
GRACE PATRICK PFirst filing | Director | Sale | 60 | $26K | May 8 | +26.0% | SEC ↗ |
| president and CEO | Sale | 2,000 | $842K | May 4 | +25.5% | SEC ↗ | |
| president and CEO | Sale | 1,500 | $554K | Mar 30 | — | SEC ↗ | |
MCNAMARA KEVIN JFirst in 4 months | president and CEO | Sale | 2,000 | $806K | Mar 13 | — | SEC ↗ |
MCNAMARA KEVIN JFirst filing | president and CEO | Sale | 2,000 | $875K | Nov 25 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading CHE 10 all-time
- RRep. Lisa C. McClainPurchase$1,001 - $15,0002025-06-24
- RRep. Byron DonaldsSale$1,001 - $15,0002025-03-06
- RRep. Byron DonaldsSale$1,001 - $15,0002025-03-06
- DRep. Ro KhannaSale$1,001 - $15,0002024-02-13
- DRep. Daniel GoldmanSale$1,001 - $15,0002023-01-31
- DRep. Ro KhannaPurchase$1,001 - $15,0002023-01-11
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does CHE have?
CHEMED CORP (CHE) has 32 SEC Form 4 filings (44 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Oct 1, 2026.
When was the most recent SEC Form 4 filing for CHE?
The most recent Form 4 filing for CHE on Tracefour is dated Oct 1, 2026.
Who is the most active insider at CHE?
The most active SEC Form 4 filer at CHE in the rolling window is president and CEO MCNAMARA KEVIN J, with 8 filings.
What is the net insider flow at CHE over the last 6 months?
Over the trailing 180 days, insiders at CHE have net sold $6.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CHE in the current window?
Inside the rolling window, insiders at CHE bought $0 and sold $8.8M based on SEC Form 4 filings.
Can I get alerts for CHE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at CHEMED CORP (CHE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
CHEMED CORP is in the Healthcare sector.